Literature DB >> 9789845

Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease.

F Whittom1, J Jobin, P M Simard, P Leblanc, C Simard, S Bernard, R Belleau, F Maltais.   

Abstract

PURPOSE AND METHODS: In this study, we examined the fiber-type proportions, cross-sectional areas (CSA), and capillarization from needle biopsies of the vastus lateralis muscle in 20 patients with chronic obstructive pulmonary disease (COPD) (FEV1 = 37 +/- 11% predicted, peak VO2 = 13 +/- 4 mL.min-1.kg-1) and nine age-matched normal subjects (peak VO2 = 33 +/- 7 mL.min-1.kg-1). The effects of endurance training on these parameters were also evaluated in 11 of the 20 patients with COPD.
RESULTS: The proportion of Type I fiber was smaller in COPD than normals (34 +/- 14% vs 58 +/- 16 in normals, P < 0.0005) with a corresponding increase in Type IIb fiber (P = 0.015). The CSA of Type I, IIa, and IIab fibers was also smaller in COPD. The capillary to fiber ratio tended to be reduced in patients, but this difference did not reach statistical significance (P = 0.15). The number of capillary contact for Type I, IIa, and IIab fibers was significantly reduced in COPD compared with normal subjects (P < 0.05). When corrected for the CSA, this parameter was similar for both groups. After training, peak VO2 increased by 11% (P < 0.05), the fiber-type proportion remained unchanged, and the CSA of Type I and IIa fibers increased by 31 and 21%, respectively (P < 0.05). Although the number of capillary contact for each fiber types increased with training, the capillary to fiber ratio and the number of capillary contact for the different fiber types relative to their CSA remain unchanged.
CONCLUSIONS: We conclude that in COPD, 1) the vastus lateralis muscle is characterized by a marked decrease in Type I fiber proportion, an increase in Type IIb fiber proportion, a decrease in Type I, IIa, and IIab fiber CSA and by a relatively preserved capillarization; and 2) a 12-wk training program induces a significant increase in Type I and IIa CSA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789845     DOI: 10.1097/00005768-199810000-00001

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  96 in total

Review 1.  Enhancing physical performance in chronic obstructive pulmonary disease.

Authors:  M C Steiner; M D Morgan
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

Review 2.  Respiratory muscle fibres: specialisation and plasticity.

Authors:  B Polla; G D'Antona; R Bottinelli; C Reggiani
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

3.  Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease.

Authors:  C Koechlin; F Maltais; D Saey; A Michaud; P LeBlanc; M Hayot; C Préfaut
Journal:  Thorax       Date:  2005-06-17       Impact factor: 9.139

4.  Effects of hypoxia on muscle protein synthesis and anabolic signaling at rest and in response to acute resistance exercise.

Authors:  Timothy Etheridge; Philip J Atherton; Daniel Wilkinson; Anna Selby; Debbie Rankin; Nick Webborn; Kenneth Smith; Peter W Watt
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-12       Impact factor: 4.310

5.  Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans.

Authors:  S C Erzurum; S Ghosh; A J Janocha; W Xu; S Bauer; N S Bryan; J Tejero; C Hemann; R Hille; D J Stuehr; M Feelisch; C M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

Review 6.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

7.  Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.

Authors:  Ioannis Vogiatzis; Grigoris Stratakos; Davina C M Simoes; Gerasimos Terzis; Olga Georgiadou; Charis Roussos; Spyros Zakynthinos
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

8.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Influence of a moderate physical activity intervention on red cell deformability in patients suffering from chronic obstructive pulmonary disease (COPD).

Authors:  Basit Ahmad; Nina Ferrari; Georgina Montiel; Wilhelm Bloch; Anke Raabe-Oetker; Nina Skrobala; Klara Brixius
Journal:  Wien Med Wochenschr       Date:  2013-02-20

10.  Exposure to cigarette smoke induces overexpression of von Hippel-Lindau tumor suppressor in mouse skeletal muscle.

Authors:  Vladimir T Basic; Elsa Tadele; Ali Ateia Elmabsout; Hongwei Yao; Irfan Rahman; Allan Sirsjö; Samy M Abdel-Halim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.